Form 4: Danaher Officer Granted RSUs, Stock Options

Danaher's VP, Chief Accounting Officer, Christopher Bouda, reported the grant of restricted stock units and employee stock options.

Summary

• Christopher Bouda, VP, Chief Accounting Officer at Danaher Corporation, reported transactions on March 1, 2026.
• He was granted 1,247 restricted stock units (RSUs) of common stock, which will vest 25% annually over four years starting March 1, 2026.
• He also received 3,369 employee stock options with an exercise price of $210.64, which become exercisable 25% annually over four years starting March 1, 2026, and expire on March 1, 2036.
• A disposition of 170 shares of common stock occurred at $210.64, likely for tax withholding purposes related to the equity awards.
• Following these transactions, Bouda directly owns 9,167 shares and indirectly owns 677.227 shares through a 401(k) plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices that align management's interests with long-term shareholder value, without indicating any immediate operational or financial shifts.

Positives

• Grant of 1,247 restricted stock units (RSUs) aligns management's interests with long-term shareholder value.
• Grant of 3,369 employee stock options provides an incentive for future performance and stock price appreciation.

Negatives

• Disposition of 170 shares of common stock at $210.64, likely for tax withholding, reduces direct beneficial ownership slightly.

Future Outlook

The restricted stock units and employee stock options granted to Christopher Bouda are structured with a four-year vesting/exercisability schedule, with 25% vesting/becoming exercisable on each anniversary of the March 1, 2026 grant date. This indicates a long-term incentive structure for management.

Industry Context

StockSavvy.ai notes that equity grants to executives, such as RSUs and stock options, are standard practice across industries, particularly in large, established companies like Danaher. These grants are designed to align executive incentives with long-term shareholder value creation and retention. The specific terms (e.g., four-year vesting) are typical for such compensation structures.

Comparison to Industry Standards

• The four-year vesting schedule for RSUs and options is a common industry standard for executive equity compensation, comparable to practices at peer companies in the diversified industrial and life sciences sectors such as Thermo Fisher Scientific (TMO) or Agilent Technologies (A).
• The grant of both RSUs (full value shares) and stock options (leveraged upside) is a balanced approach to executive incentives, often seen in companies aiming to reward both retention and stock price growth.

Related Party Transactions

• The grant of 1,247 restricted stock units and 3,369 employee stock options to Christopher Bouda, a VP and Chief Accounting Officer, constitutes a related party transaction as part of executive compensation.

Stakeholder Impact

• Shareholders: The grants align executive incentives with shareholder interests, potentially leading to better long-term performance.
• Employees: No direct impact on general employees is indicated, but it reflects the company's executive compensation strategy.

Next Steps

• 25% of the granted restricted stock units will vest on each of the first four anniversaries of March 1, 2026.
• 25% of the granted employee stock options will become exercisable on each of the first four anniversaries of March 1, 2026.

Key Dates

Recommendation

This Form 4 filing details routine executive compensation in the form of equity grants. While these grants align management incentives with shareholder value, they do not provide new material information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It's a standard disclosure for insider transactions.

Keywords

Danaher, DHR, SEC Form 4, Insider Trading, Restricted Stock Units, Stock Options, Executive Compensation, Equity Grant, Christopher Bouda